Kuopio [Finland], January 29 (ANI): The first thing that any doctor suggests to a patient diagnosed with diabetes is, regular physical exercise. Now, a study from the University of Eastern Finland has made positive discoveries about physical activity's role in the protection against type 2 d
Washington [US], January 27 (ANI): Although type 1 diabetes is traditionally considered a disease of lean people, overweight and obesity are becoming increasingly more common in individuals with type 1 diabetes. A new study has said that people with type 1 diabetes should be screened regular
Uxbridge [England], January 26 (ANI): It is often observed that some people with obesity remain relatively healthy, whilst others suffer from life-changing ailments such as type 2 diabetes and heart disease.
Washington [US], January 16 (ANI): Less than one in five adults with Type 2 diabetes in the US meet health targets to reduce heart disease risk, a new study has found.
Washington [US], January 11 (ANI): A new study has found that fewer than one in five adults with Type 2 diabetes in the US are meeting health targets to reduce heart disease risk.
Birmingham [UK], January 5 (ANI): A research at the University of Birmingham has shown for the first time the scale of the impact of a condition associated with benign tumours that can lead to type 2 diabetes and high blood pressure.
Washington [US], December 30 (ANI): A new study has found that the prevalence of type 2 diabetes (T2D) is elevated in people with a psychiatric disorder compared with the general population.
Berlin (Germany), December 22 (ANI): A new study has found that intensive lifestyle intervention helps people with prediabetes delay or even prevent type 2 diabetes.
Bengaluru (Karnataka) [India], December 18 (ANI/BusinessWire India): Twin Health, makers of the Whole-Body Digital Twin™ technology, today announced the appointment of Prabh Singh as the CEO for its India operations. Founded in 2018, Twin Health invented the Whole-Body Digital Twin&
Bath [UK], December 10 (ANI): A team of scientists at the University of Bath have refined a molecule that shows promise in preventing Parkinson's disease. It has the potential to develop into a drug to treat the deadly neurodegenerative disease.